株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品添加剤の世界市場:製品・機能・地域別 市場予測

Pharmaceutical Excipients Market: By Product ; By Chemistry ; By Route of Administration ; By Functionality ; By Geography - Forecast 2018-2023

発行 IndustryARC 商品コード 422631
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
医薬品添加剤の世界市場:製品・機能・地域別 市場予測 Pharmaceutical Excipients Market: By Product ; By Chemistry ; By Route of Administration ; By Functionality ; By Geography - Forecast 2018-2023
出版日: 2018年12月14日 ページ情報: 英文
概要

当レポートでは、医薬品添加剤の世界市場について調査し、製品・機能・地域別の市場動向および市場成長予測、市場の促進・抑制要因、市場の機会・課題、戦略分析、主要企業のプロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 医薬品添加剤の世界市場:戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品/市場のライフサイクル分析
  • 供給・流通

第6章 医薬品添加剤の世界市場:製品別

  • 有機化学製品
  • 無機化学製品
  • その他

第7章 医薬品添加剤の世界市場:機能別

  • 充填・希釈剤
  • 結合剤
  • 懸濁・粘着剤
  • コーティング
  • 錠剤分解剤
  • 香味料
  • 潤滑・流動促進剤
  • 着色料
  • 保存料
  • その他

第8章 医薬品添加剤の世界市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他の国々
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他の国々
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域

第9章 医薬品添加剤の世界市場:エントロピー

  • 市場の拡大
  • 技術の進歩
  • 合併・買収・合弁事業
  • 供給契約

第10章 企業プロファイル

第11章 付録

目次

Pharmaceutical excipients market is classified as organic and inorganic based on the type of pharmaceutical excipient products commercially available. Rise in healthcare expenditures, demand for new drug delivery systems along with need for enhanced medications are generating impetuous on pharmaceutical excipients market. Various pharmaceutical excipients are used for different drugs depending up on the complexity of the diseases. Another trend that drives the growth of this market is extensive research on the excipients that has given a better understanding of their functional benefits, thus their inclusion in the drug formulation has increased.

The pharmaceutical excipient production has been boosted with the advent in industries particularly pharmaceutical industry. Excipient quality plays a vital role in assuring safety, quality and efficacy of dosage forms. Standardization of excipients usually assures the customers of uniform quality across pharmaceutical products, while manufactures are assured of standardized prices of these excipients. The increased spending on healthcare by developing countries is set to increase the utilization of pharmaceutical excipients.

Binders segment is poised to dominate this market during 2017-2023.The pharmaceutical excipients market had total revenue estimated to $4256.3 million in 2017 which is expected to grow at rate of 6% till forecasted year 2023. The enormous potential for pharmaceutical excipients is also indicated by growing healthcare expenditures, rising income levels and improving health awareness amongst peoples.

What are Pharmaceutical Excipients?

An excipient can be defined as pharmacologically inactive substance in the drug delivery system which is formulated with the active pharmaceutical ingredient of a medication to prepare the product in a consumable form. Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. They enhance the properties such as bulkiness of the pharmaceutical formulation so that it can be consumed in proper manner. It also promotes the drug absorption quality of the pharmaceutical product. They do not react unwillingly with the drug and help to achieve desired drug functionality. Novel and increasingly complex excipients have been developed as the novel drug formulation delivery systems have emerged and evolved.

What are the major applications for Pharmaceutical Excipients?

Excipients are vital in formulating a dosage form of the drug or any pharmaceutical product, for adding bulk to solids (formulas) and also to facilitate proper absorption. These ingredients make up the dosage forms along with active pharmaceutical ingredients. They act as protective agents, bulking agents, flavoring and coloring agents and can also be used to improve bioavailability of drugs in some instances.

Many excipients are potential toxicants at high doses in animals, though safe in humans at therapeutic doses, including commonly used excipients such as cyclodextrins, dextran, and polyethylene glycol. Pharmaceutical excipients are vital in processing stage as they help to improve the processing of the drug delivery system during its manufacture itself. They protect, support, or enhance stability, or patient acceptability of the drug. They also assist in product identification, and enhance attributes of the overall safety in storage and also in maintaining the integrity of the drug product during storage.

Pharmaceutical Excipients Market

Market Research and Market Trends of Pharmaceutical Excipients Ecosystem

New technologies related to the controlled release of small molecule drugs have been introduced in recent developments. Lubrizol LifeScience Polymers (LSP) has introduced its Pathway pharmaceuticalgrade thermoplastic polyurethane (TPU) excipients which offer controlled release in drug delivery systems and other applications. Lubrizol is now producing the materials under GMP conditions, which allows their use as excipients.

EMD Millipore introduced Parteck SRP 80 which is a new polyvinyl alcohol (PVA)-based functional excipient. It is specifically designed for oral sustained-release formulations, particularly direct-compression processes. Manufacturers have promised its reliable performance profile and ability to facilitate the development of robust and cost-efficient manufacturing processes.

MannKind Corporation has developed (AFREZZA) a non-injectable (orally inhaled) mealtime insulin therapy for improving glycemic control in adult patients with diabetes mellitus. MannKind is exploring the potential application of this technology for the pulmonary delivery of other drug substances. A novel excipient-fumaryl diketopiperazine (FDKP)-is inert and serves as a particle matrix (crystalline or amorphous) enhances effectiveness of the inhaled form of insulin. It carries the active drug and dissolves at the prevailing physiological pH in the lungs, where it is absorbed into the systemic circulation. Cipla tied with MannKind recently and will be responsible for obtaining regulatory approvals to distribute Afrezza in India, including approval from the Drug Controller General of India (DCGI).

The material 'Upsalite' has been developed by company Disruptive Materials. It was first synthesized by researchers at Uppsala University; it is highly porous with a very large surface area and enables the controlled release of APIs including ibuprofen. It has been commercialized as a water-free, disordered, amorphous magnesium carbonate. It is thought that trapping of the drug molecules in the narrow pores of the material prevents them from adopting a poorly soluble, crystalline form.

Pharmaceutical formulation experts are continuously working to improve the manufacturing process and product quality by using multi-functional excipients. It can help pharma manufacturing by improving flowability, enhancing compressibility, improving bioavailability, particle size distribution and reduced dust generation, etc. Evonik's newly launched EUDRAGIT FS 100 is a solid version of existing EUDRAGIT FS 30 D. It allows pharmaceutical companies to use the polymer in various applications, such as hot melt extrusion, solvent spray-drying and solvent coating, which was impossible to achieve in prior decades where only the aqueous version was available. This multi-functionality approach allows overall new development possibilities within the pharmacy industry.

Who are the Major Players in Pharmaceutical Excipients market?

The players profiled in the report include BASF SE, Dow Chemical, FMC Chemical and Nutrition, Fuji Chemical Industry, Evonik, Ashland Inc., Roquette Group, The Lubrizol Corp., Colorcon, Croda International Plc.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Pharmaceutical excipients Market - Overview

2. Executive Summary

3. Pharmaceutical excipients Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Pharmaceutical excipients Market- Forces

  • 4.1. Drivers
    • 4.1.1. Growth of the Global Pharmaceuticals Market Backed By Functional Excipients
    • 4.1.2. Patent Cliffs Driving the Growth of Excipients in the Generics Market
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Pharmaceutical excipients Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Pharmaceutical excipients Market, By Product

  • 6.1. Organic Chemicals
  • 6.2. Inorganic Chemicals
  • 6.3. Others

7. Pharmaceutical excipients Market, By Functionality

  • 7.1. Fillers & Diluents
  • 7.2. Binders
  • 7.3. Suspension & Viscosity Agents
  • 7.4. Coatings
  • 7.5. Disintegrants
  • 7.6. Flavoring Agents
  • 7.7. Lubricants & Glidants
  • 7.8. Colorants
  • 7.9. Preservatives
  • 7.10. Others

8. Pharmaceutical excipients Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Pharmaceutical excipients Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Ashland Inc.
  • 10.2. BASF SE
  • 10.3. The DOW Chemical Company
  • 10.4. FMC Corporation
  • 10.5. Roquette Group
  • 10.6. Evonik Industries AG
  • 10.7. Associated British Foods PLC
  • 10.8. The Lubrizol Corporation
  • 10.9. Archer Daniels Midland Company
  • 10.10. Croda International PLC

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top